Nanoparticles disguised as red blood cells to evade the immune system

Figures & data

Figure 1. Illustration of personalized therapy using the red blood cell (RBC) membrane-coated nanoparticle platform. Blood is drawn from a patient and processed in order to derive nanoscale vesicles from RBC membranes. These vesicles are then used to coat drug-loaded nanoparticles. Finally, the treatment formulation is injected back into the same patient.